65 related articles for article (PubMed ID: 25879151)
1. Mole modifications following controlled ovarian stimulation for assisted reproduction technologies.
Auriemma M; Di Nicola M; Varrati S; Carbone A; Pamio A; Capo A; Tracanna M; Castigliego AP; Tiboni GM; Amerio P
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1913-7. PubMed ID: 25879151
[TBL] [Abstract][Full Text] [Related]
2. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
[TBL] [Abstract][Full Text] [Related]
3. Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome?
La Marca A; Pati M; Giulini S; Levratti P; Caretto S; Volpe A
Gynecol Endocrinol; 2005 Nov; 21(5):292-4. PubMed ID: 16373249
[TBL] [Abstract][Full Text] [Related]
4. Falling estradiol levels on day after human chorionic gonadotropin administration in assisted reproductive technology cycles are not predictive of decreasing oocyte maturity or pregnancy rates.
Levy G; Hill M; Beall S; Pilgrim JD; Payson M; Propst A
J Reprod Med; 2014; 59(5-6):255-9. PubMed ID: 24937966
[TBL] [Abstract][Full Text] [Related]
5. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study.
Humaidan P; Ejdrup Bredkjaer H; Westergaard LG; Yding Andersen C
Fertil Steril; 2010 Feb; 93(3):847-54. PubMed ID: 19200959
[TBL] [Abstract][Full Text] [Related]
6. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology.
Moon SY; Choi YS; Ku SY; Kim SH; Choi YM; Kang IS; Kim CH
J Obstet Gynaecol Res; 2007 Jun; 33(3):305-15. PubMed ID: 17578360
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled dose-response pilot study of addition of hCG to recombinant FSH during controlled ovarian stimulation for in vitro fertilization.
Thuesen LL; Loft A; Egeberg AN; Smitz J; Petersen JH; Andersen AN
Hum Reprod; 2012 Oct; 27(10):3074-84. PubMed ID: 22791754
[TBL] [Abstract][Full Text] [Related]
9. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
[TBL] [Abstract][Full Text] [Related]
10. Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens.
van Santbrink EJ; Fauser BC
J Clin Endocrinol Metab; 1997 Nov; 82(11):3597-602. PubMed ID: 9360513
[TBL] [Abstract][Full Text] [Related]
11. A novel protocol of ovulation induction with delayed gonadotropin-releasing hormone antagonist administration combined with high-dose recombinant follicle-stimulating hormone and clomiphene citrate for poor responders and women over 35 years.
D'Amato G; Caroppo E; Pasquadibisceglie A; Carone D; Vitti A; Vizziello GM
Fertil Steril; 2004 Jun; 81(6):1572-7. PubMed ID: 15193479
[TBL] [Abstract][Full Text] [Related]
12. The effect of low dose human chorionic gonadotropin on follicular response and oocyte maturation in PCOS patients undergoing IVF cycles: a randomized clinical trial of efficacy and safety.
Ashrafi M; Kiani K; Ghasemi A; Rastegar F; Nabavi M
Arch Gynecol Obstet; 2011 Dec; 284(6):1431-8. PubMed ID: 21210134
[TBL] [Abstract][Full Text] [Related]
13. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
[TBL] [Abstract][Full Text] [Related]
14. Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction.
Manna C; Rahman A; Sbracia M; Pappalardo S; Mohamed EI; Linder R; Nardo LG
Gynecol Endocrinol; 2005 Apr; 20(4):188-94. PubMed ID: 16019360
[TBL] [Abstract][Full Text] [Related]
15. In vivo reflectance confocal microscopy of equivocal melanocytic lesions detected by digital dermoscopy follow-up.
Lovatto L; Carrera C; Salerni G; Alós L; Malvehy J; Puig S
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1918-25. PubMed ID: 25752663
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
Palomba S; Falbo A; Orio F; Manguso F; Russo T; Tolino A; Annamaria C; Dale B; Zullo F
Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
[TBL] [Abstract][Full Text] [Related]
18. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
Sudik R; Fliess FR; Kunkel S
Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
[TBL] [Abstract][Full Text] [Related]
19. Elevated day 3 follicle-stimulating hormone in younger women: is gonadotropin stimulation/intrauterine insemination a good option?
Souter I; Dimitriadis I; Baltagi LM; Meeker JD; Petrozza JC
Am J Obstet Gynecol; 2014 Jul; 211(1):62.e1-8. PubMed ID: 24487006
[TBL] [Abstract][Full Text] [Related]
20. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol.
Griesinger G; Schultze-Mosgau A; Dafopoulos K; Schroeder A; Schroer A; von Otte S; Hornung D; Diedrich K; Felberbaum R
Hum Reprod; 2005 May; 20(5):1200-6. PubMed ID: 15665010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
